Tie-2 Inhibitor (Abbott)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameTie-2 Inhibitor (Abbott)
Drug Alias NameA-422885.66A-422885A-785845A-416221BSF-421386 +[6] 
ClassificationSmall molecules
Mechanisms of ActionAngiogenesis inhibitorsAnticancer protein kinase inhibitorsTEK receptor tyrosine kinase antagonists
TargetsTEK receptor tyrosine kinase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAbbott Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbbott Laboratories
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A